TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes

BACKGROUND: Despite advancements in the treatment of primary and metastatic breast cancer, many patients lack a durable response to these treatments. Patients with triple-negative breast cancer (TNBC) and human epidermal growth factor receptor 2(HER2)-positive breast cancer who do not have a patholo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Care (Basel)
Main Authors: Würfel, Franziska, Erber, Ramona, Huebner, Hanna, Hein, Alexander, Lux, Michael P., Jud, Sebastian, Kremer, Anita, Kranich, Hannah, Mackensen, Andreas, Häberle, Lothar, Hack, Carolin C., Rauh, Claudia, Wunderle, Marius, Gaß, Paul, Rabizadeh, Shahrooz, Brandl, Anna-Lisa, Langemann, Hanna, Volz, Bernhard, Nabieva, Naiba, Schulz-Wendtland, Rüdiger, Dudziak, Diana, Beckmann, Matthias W., Hartmann, Arndt, Fasching, Peter A., Rübner, Matthias
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger GmbH 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6016056/
https://ncbi.nlm.nih.gov/pubmed/29950961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486949
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados